Please login to the form below

Not currently logged in

Envision Pharma acquires Alligent Biopharm Consulting

Aims to further optimise medical communications
Alligent Logo

Envision pharma has acquired Alligent Biopharm Consulting, a leading medical affairs agency that develops medical communications solutions for the biopharma industry.

The deal was supported by the Halifax Group, which partnered with Envision management to provide the equity investment to facilitate the acquisition. 

Brian Hepburn, CEO at Envision, said: “The addition of Alligent to the Envision Pharma Group further cements our core tenet of becoming the leading international medical affairs agency.

“By acquiring Alligent, we are able to expand the capabilities we offer to medical affairs teams to ensure optimal evidence communication and ultimate product adoption based on scientific rigor.”

Alligent's two principals, Joe Kohles and David Thompson in a joint statement, said: “Our focus on medical strategy, coupled with Envision's global presence and technology leadership position, offers the potential for us to expand and enrich our service breadth and offering to current and future clients alike.

“We look forward to joining the Group's leadership team and contributing to the continued success of both Alligent and Envision.” 

11th September 2015

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...